CBDX — Curative Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.16m
Annual cashflow statement for Curative Biosciences, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2013 June 30th | 2014 June 30th | 2015 June 30th | 2016 June 30th | 2017 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.64 | -30 | -3.37 | -1.66 | -0.053 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 6.29 | 29.5 | 2.91 | 1.74 | 0.037 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.123 | 0.303 | 0.388 | -0.113 | 0 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.157 | -0.144 | -0.065 | -0.029 | -0.013 |
| Capital Expenditures | -0.001 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.001 | 0 | 0 | 0 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.172 | 0.144 | 0.066 | 0.027 | 0.013 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.014 | 0 | 0 | -0.002 | 0 |